THE CONAFAY GROUP, LLC

Lobbying for REVAGENIX, INC. · Biopharmaceutical company creating anti-infective medicines.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $50,000.00 income · posted Jul 20, 2026

Lobbying activity 2

Health Issues

Opportunities to promote antimicrobial drug development.

Medical/Disease Research/Clinical Labs

Opportunities to promote antimicrobial drug development.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.